At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
social supportbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 14, 2016
In Brief
A Phase 3 clinical trial evaluating social support for Cardiovascular Diseases and 5 related conditions. Completed.
Detailed Summary
To evaluate the effect of psychosocial intervention on mortality and reinfarction in coronary heart disease patients at high psychosocial risk.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Depression, Heart Diseases, Myocardial Infarction, Myocardial Ischemia
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1995
First PostedOct 1999
Primary CompletionSep 2005
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartSep 1, 1995
Primary CompletionSep 1, 2005
TodayJul 2, 2026
Enrollment to primary: 10 yearsPosted 26.7 years ago
Interventions
social supportbehavioral